Real world evidence from more than 144,000 people with diabetes

Clinically significant glucose improvements seen in real world evidence of patients using the OneTouch Reveal® app and the OneTouch Verio Flex® meter at 6 months*.

Clinical data glucose diabetes
Mean Blood glucose diabetes
Hyperglycemic data diabetes
Clinical data glucose diabetes
Mean Blood glucose diabetes
Hyperglycemic data diabetes

    Methods: Anonymized glucose and app analytics were extracted from a server from more than 144,000 people with diabetes (PWDs). Data from their first 14 days using the OneTouch Reveal® app and OneTouch Verio Flex® meter were compared with 14 days prior to 90- and 180-day timepoints using paired within-subject differences.

      People with type 1 diabetes (PwT1D),

      • Readings in-range (RIR) improved by +6.1 (54.5% to 60.6%).
      • Hyperglycemia was reduced by −6.6 (40.5% to 33.9%).
      • People with type 1 diabetes spending two to four sessions or 10 to 20 minutes per week on the app improved RIR by +5.1 and 7.0, respectively.
      • Mean blood glucose (BG) reduced by −11.4 from baseline to 180 days, with no clinically meaningful changes in percentage of hypoglycemic readings. All glycemic changes were statistically significant (P < .0005 level).

      People with type 2 diabetes (PwT2D),

      • Readings in-range (RIR) improved by +11.9 percentage points (68.2% to 80.1%).
      • Hyperglycemia was reduced by −12.0 (30.3% to 18.3%).
      • People with type 2 diabetes spending two to four sessions or 10 to 20 minutes per week on the app improved RIR by +11.6 and 12.0, respectively.
      • Mean BG reduced by −19.5 mg/dL from baseline to 180 days, with no clinically meaningful changes in percentage of hypoglycemic readings. All glycemic changes were statistically significant (P <. 0005 level).

        Real-world data from more than 144 000 PWD demonstrated improved percentage readings in-range and reduced hyperglycemia in people with diabetes using the OneTouch Reveal® app and OneTouch Verio Flex® blood glucose meter.

        * Grady M, Cameron H, Holt E. Improved Glycemic Control Using a Bluetooth®-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144 000 People With Diabetes. Journal of Diabetes Science and Technology.
        2023;0(0). doi:10.1177/19322968221148764

        US-DMV-2300009

        This information is for general background purposes and is not a substitute for medical advice or treatment for specific conditions. Seek prompt medical attention for healthcare questions you have. Consult your physician before making changes to your medication, diet, fitness program, or blood glucose testing schedules.
        The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by LifeScan Scotland Ltd. and its affiliates is under license. Other trademarks and trade names are those of respective owners. © 2018-2023 LifeScan IP Holdings, LLC. All rights reserved.
        This site, intended for visitors from the United States, is published by LifeScan, Inc., which is solely responsible for its contents. By using this site, you agree to our Legal Notice and Privacy Policy